US Stock MarketDetailed Quotes

Creative Medical Technology (CELZ)

Watchlist
  • 2.470
  • +0.140+6.01%
Close Apr 17 16:00 ET
  • 2.400
  • -0.070-2.83%
Post 19:21 ET
9.13MMarket Cap-0.98P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Creative Medical Technology (CELZ) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-45.45%6K
0.00%3K
0
0
3K
22.22%11K
0.00%3K
0
8K
0
Operating revenue
-45.45%6K
0.00%3K
--0
--0
--3K
22.22%11K
0.00%3K
--0
--8K
--0
Cost of revenue
-50.14%2.19K
-17.17%994
0
0
1.2K
22.22%4.4K
0.00%1.2K
0
3.2K
0
Gross profit
-42.33%3.81K
11.44%2.01K
0
0
1.8K
22.22%6.6K
0.00%1.8K
0
4.8K
0
Operating expense
6.89%6.15M
3.19%1.95M
14.72%1.27M
-22.49%1.26M
48.00%1.66M
2.22%5.75M
6.42%1.89M
-28.26%1.11M
36.75%1.63M
0.91%1.12M
Selling and administrative expenses
16.18%3.76M
-1.89%1.37M
55.80%776.82K
8.20%731.52K
32.30%888.4K
-9.02%3.24M
-0.40%1.39M
-6.11%498.61K
-21.34%676.09K
-12.91%671.48K
Research and development costs
-5.87%2.26M
16.58%550.08K
-20.05%465.15K
-45.79%501.26K
75.97%743.3K
21.83%2.4M
35.04%471.84K
-41.39%581.8K
198.81%924.75K
32.40%422.39K
Depreciation amortization depletion
11.66%123.33K
36.71%30.95K
6.11%31.06K
5.03%30.74K
4.46%30.58K
16.78%110.45K
-11.29%22.64K
27.15%29.27K
27.15%29.27K
27.15%29.27K
-Depreciation and amortization
11.66%123.33K
36.71%30.95K
6.11%31.06K
5.03%30.74K
4.46%30.58K
16.78%110.45K
-11.29%22.64K
27.15%29.27K
27.15%29.27K
27.15%29.27K
Operating profit
-6.95%-6.14M
-3.18%-1.95M
-14.72%-1.27M
22.26%-1.26M
-47.84%-1.66M
-2.20%-5.74M
-6.43%-1.89M
28.09%-1.11M
-36.35%-1.63M
-0.91%-1.12M
Net non-operating interest income expense
-40.97%147.81K
83.54%58.11K
-46.65%37.1K
-55.29%30.22K
-72.57%22.38K
-24.94%250.38K
-66.05%31.66K
-22.07%69.54K
-24.84%67.58K
33.45%81.6K
Non-operating interest income
-40.97%147.81K
83.54%58.11K
-46.65%37.1K
-55.29%30.22K
-72.57%22.38K
-24.94%250.38K
-66.05%31.66K
-22.07%69.54K
-24.84%67.58K
33.34%81.6K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
--0
Other net income (expense)
Income before tax
-9.13%-6M
-1.81%-1.89M
-18.82%-1.24M
20.83%-1.23M
-57.28%-1.64M
-3.91%-5.49M
-10.46%-1.85M
28.46%-1.04M
-41.34%-1.56M
0.99%-1.04M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-9.13%-6M
-1.81%-1.89M
-18.82%-1.24M
20.83%-1.23M
-57.28%-1.64M
-3.91%-5.49M
-10.46%-1.85M
28.46%-1.04M
-41.34%-1.56M
0.99%-1.04M
Net income continuous Operations
-9.13%-6M
-1.81%-1.89M
-18.82%-1.24M
20.83%-1.23M
-57.28%-1.64M
-3.91%-5.49M
-10.46%-1.85M
28.46%-1.04M
-41.34%-1.56M
0.99%-1.04M
Minority interest income
Net income attributable to the parent company
-9.13%-6M
-1.81%-1.89M
-18.82%-1.24M
20.83%-1.23M
-57.28%-1.64M
-3.91%-5.49M
-10.46%-1.85M
28.46%-1.04M
-41.34%-1.56M
0.99%-1.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.13%-6M
-1.81%-1.89M
-18.82%-1.24M
20.83%-1.23M
-57.28%-1.64M
-3.91%-5.49M
-10.46%-1.85M
28.46%-1.04M
-41.34%-1.56M
0.99%-1.04M
Basic earnings per share
32.08%-2.52
28.57%-0.8
36.00%-0.48
56.76%-0.48
-13.70%-0.83
1.33%-3.71
7.44%-1.12
26.47%-0.75
-42.31%-1.11
2.67%-0.73
Diluted earnings per share
32.08%-2.52
28.57%-0.8
36.00%-0.48
56.76%-0.48
-13.70%-0.83
1.33%-3.71
7.44%-1.12
26.47%-0.75
-42.31%-1.11
2.67%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -45.45%6K0.00%3K003K22.22%11K0.00%3K08K0
Operating revenue -45.45%6K0.00%3K--0--0--3K22.22%11K0.00%3K--0--8K--0
Cost of revenue -50.14%2.19K-17.17%994001.2K22.22%4.4K0.00%1.2K03.2K0
Gross profit -42.33%3.81K11.44%2.01K001.8K22.22%6.6K0.00%1.8K04.8K0
Operating expense 6.89%6.15M3.19%1.95M14.72%1.27M-22.49%1.26M48.00%1.66M2.22%5.75M6.42%1.89M-28.26%1.11M36.75%1.63M0.91%1.12M
Selling and administrative expenses 16.18%3.76M-1.89%1.37M55.80%776.82K8.20%731.52K32.30%888.4K-9.02%3.24M-0.40%1.39M-6.11%498.61K-21.34%676.09K-12.91%671.48K
Research and development costs -5.87%2.26M16.58%550.08K-20.05%465.15K-45.79%501.26K75.97%743.3K21.83%2.4M35.04%471.84K-41.39%581.8K198.81%924.75K32.40%422.39K
Depreciation amortization depletion 11.66%123.33K36.71%30.95K6.11%31.06K5.03%30.74K4.46%30.58K16.78%110.45K-11.29%22.64K27.15%29.27K27.15%29.27K27.15%29.27K
-Depreciation and amortization 11.66%123.33K36.71%30.95K6.11%31.06K5.03%30.74K4.46%30.58K16.78%110.45K-11.29%22.64K27.15%29.27K27.15%29.27K27.15%29.27K
Operating profit -6.95%-6.14M-3.18%-1.95M-14.72%-1.27M22.26%-1.26M-47.84%-1.66M-2.20%-5.74M-6.43%-1.89M28.09%-1.11M-36.35%-1.63M-0.91%-1.12M
Net non-operating interest income expense -40.97%147.81K83.54%58.11K-46.65%37.1K-55.29%30.22K-72.57%22.38K-24.94%250.38K-66.05%31.66K-22.07%69.54K-24.84%67.58K33.45%81.6K
Non-operating interest income -40.97%147.81K83.54%58.11K-46.65%37.1K-55.29%30.22K-72.57%22.38K-24.94%250.38K-66.05%31.66K-22.07%69.54K-24.84%67.58K33.34%81.6K
Non-operating interest expense --------------------------------------0
Other net income (expense)
Income before tax -9.13%-6M-1.81%-1.89M-18.82%-1.24M20.83%-1.23M-57.28%-1.64M-3.91%-5.49M-10.46%-1.85M28.46%-1.04M-41.34%-1.56M0.99%-1.04M
Income tax 0000000000
Net income -9.13%-6M-1.81%-1.89M-18.82%-1.24M20.83%-1.23M-57.28%-1.64M-3.91%-5.49M-10.46%-1.85M28.46%-1.04M-41.34%-1.56M0.99%-1.04M
Net income continuous Operations -9.13%-6M-1.81%-1.89M-18.82%-1.24M20.83%-1.23M-57.28%-1.64M-3.91%-5.49M-10.46%-1.85M28.46%-1.04M-41.34%-1.56M0.99%-1.04M
Minority interest income
Net income attributable to the parent company -9.13%-6M-1.81%-1.89M-18.82%-1.24M20.83%-1.23M-57.28%-1.64M-3.91%-5.49M-10.46%-1.85M28.46%-1.04M-41.34%-1.56M0.99%-1.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.13%-6M-1.81%-1.89M-18.82%-1.24M20.83%-1.23M-57.28%-1.64M-3.91%-5.49M-10.46%-1.85M28.46%-1.04M-41.34%-1.56M0.99%-1.04M
Basic earnings per share 32.08%-2.5228.57%-0.836.00%-0.4856.76%-0.48-13.70%-0.831.33%-3.717.44%-1.1226.47%-0.75-42.31%-1.112.67%-0.73
Diluted earnings per share 32.08%-2.5228.57%-0.836.00%-0.4856.76%-0.48-13.70%-0.831.33%-3.717.44%-1.1226.47%-0.75-42.31%-1.112.67%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -